Charles D. Pusey

37.5k citations

323 papers · 18.4k indexed · 5 hit papers · h-index 70

Impact in

Nephrology top 0.02%
- Renal Diseases and Glomerulopathies
Genetics top 0.05%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

Nephrology 106
- Renal Diseases and Glomerulopathies 95
Immunology and Allergy 52
- Cell Adhesion Molecules Research 52

Co-authors: David Jayne Jeremy Levy Alan D. Salama Andrew J. Rees Stephen P. McAdoo H. Terence Cook Keith B. Elkon John Lanham
Journals: Kidney International (33 papers)Journal of the American Society of Nephrology (23 papers)Nephrology Dialysis Transplantation (21 papers)Lara D. Veeken (16 papers)Clinical & Experimental Immunology (10 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Charles D. Pusey

315 papers receiving 17.9k citations

Hit Papers

5 papers align trajectories log scale

Histopathologic Classification of ANCA-Associated Glomerulonephritis 2010 · 580 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Journal of the American Society of Nephrology
2010 Annals of the Rheumatic Diseases
2007 Journal of the American Society of Nephrology
2003 New England Journal of Medicine
1984 Medicine

Peers

Countries citing papers authored by Charles D. Pusey

Since Specialization

Citations

This map shows the geographic impact of Charles D. Pusey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Pusey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Pusey more than expected).

Fields of papers citing papers by Charles D. Pusey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Pusey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Pusey. The network helps show where Charles D. Pusey may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles D. Pusey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles D. Pusey Line = papers co-authored together Charles D. Pusey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Kidney International Reports ·Stephen P. McAdoo, Ruth J. Pepper, Maria Prendecki, Amrita Dhutia, Tony Lopez, Áine Burns, Marie Condon, Sally Hamour, Megan Griffith, Jeremy Levy, Tom Cairns, Mark A. Little, Alan D. Salama, Charles D. Pusey	2025	0
2	The role of neutrophils in ANCA-associated vasculitis Immunology Letters ·Maria Prendecki, Angila Gurung, Noelle Pisacano, Charles D. Pusey	2024	1
3	The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial Kidney International ·Balazs Odler, Regina Riedl, Duvuru Geetha, Wladimir Szpirt, Carmel M. Hawley, Lisa Uchida, Zachary S. Wallace, Giles Walters, Eri Muso, Vladimı́r Tesař, Charles D. Pusey, Mark A. Little, Peter A. Merkel, Michael Walsh, David Jayne, Andreas Kronbichler, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	3
4	Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis Expert Review of Clinical Immunology ·Kavita Gulati, Charles D. Pusey	2023	2
5	Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Arthritis & Rheumatology ·Maria Prendecki, Kavita Gulati, Noelle Pisacano, Damilola Pinheiro, Tejal Bhatt, Marie‐Anne Mawhin, Frédéric Toulza, Esteban S. Masuda, Andrew S. Cowburn, Katharine M. Lodge, Frederick W.K. Tam, Candice Roufosse, Charles D. Pusey, Stephen P. McAdoo	2022	9
6	Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model Kidney International ·Stephen P. McAdoo, Maria Prendecki, Anisha Tanna, Tejal Bhatt, Gurjeet Bhangal, John McDaid, Esteban S. Masuda, H. Terence Cook, Frederick W.K. Tam, Charles D. Pusey	2020	44
7	Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis The Journal of Rheumatology ·Maria Weiner, Su Mein Goh, Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, P. Sharp, Amy Kang, Annette Bruchfeld, Daina Selga, Zdeňka Chocová, Kerstin Westman, Per Eriksson, Lorraine Harper, Charles D. Pusey, Vladimı́r Tesař, Alan D. Salama, Mårten Segelmark	2019	9
8	A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis Lara D. Veeken ·Ruth J. Pepper, Stephen P. McAdoo, Sarah Moran, Dearbhla Kelly, Jennifer Scott, Sally Hamour, Áine Burns, Megan Griffith, Jack Galliford, Jeremy Levy, Thomas Cairns, Seerapani Gopaluni, Rachel Jones, David Jayne, Mark A. Little, Charles D. Pusey, Alan D. Salama	2018	58
9	Surgery for Vasculitic Disease of the Nose and Sinuses International Journal of Head and Neck Surgery ·Peter Andrews, Ivor Kwame, Charles D. Pusey	2018	4
10	Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis Kidney International ·Dearbhaile Dooley, Mirjan M. van Timmeren, Vincent O’Reilly, Gareth Brady, Eóin C. O’Brien, Barbara Fazekas, Fionnuala B. Hickey, Emma Leacy, Charles D. Pusey, Frederick W.K. Tam, Thomas Mehrling, Peter Heeringa, Mark A. Little	2018	3
11	WS7_1 Organ Damage and Hospitalization in Elderly Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Lara D. Veeken ·Maria Weiner, Su Mein Goh, Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, P. Sharp, Amy Kang, Annette Bruchfeld, Daina Selga, Zdeňka Chocová, Kerstin Westman, Per Eriksson, Lorraine Harper, Charles D. Pusey, Vladimı́r Tesař, Alan D. Salama, Mårten Segelmark	2017	11
12	Genetic Loci Modulate Macrophage Activity and Glomerular Damage in Experimental Glomerulonephritis Journal of the American Society of Nephrology ·Jacques Behmoaras, Jennifer Smith, Zelpha D’Souza, Gurjeet Bhangal, Ratana Chawanasuntoropoj, Frederick W.K. Tam, Charles D. Pusey, Timothy J. Aitman, H. Terence Cook	2010	21
13	Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis Journal of the American Society of Nephrology ·David Jayne, Gill Gaskin, Niels Rasmussen, Daniel Abramowicz, Franco Ferrario, Loı̈c Guillevin, E Mirapeix, Caroline O. S. Savage, Renato Alberto Sinico, Coen A. Stegeman, Kerstin Westman, Fokko J. van der Woude, Robert A.F. de Lind van Wijngaarden, Charles D. Pusey Hit paper breakdown →	2007	706
14	Platelet-Derived Growth Factor Reorganizes the Actin Cytoskeleton through 3-Phosphoinositide-Dependent and 3-Phosphoinositide-Independent Mechanisms in Human Mesangial Cells Nephron Physiology ·Lisa J. Harper, Yasuyo Kashiwagi, Charles D. Pusey, Bruce M. Hendry, Jan Domin	2007	7
15	Rapidly progressive glomerulonephritis: Current and evolving treatment strategies Journal of Nephrology ·Mark A. Little, Charles D. Pusey	2004	23
16	Retransplantation in Alport post-transplant anti-GBM disease Kidney International ·Gemma Browne, Paul A. Brown, Charles Tomson, Stewart Fleming, Andrew R. Allen, Richard Herriot, Charles D. Pusey, Andrew J. Rees, Neil Turner	2004	34
17	Elevated Akt Phosphorylation as an Indicator of Renal Tubular Epithelial Cell Stress Journal of Biological Chemistry ·Toshihiko Nishino, Charles D. Pusey, Jan Domin	2002	10
18	Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. BMJ ·Caroline O. S. Savage, Charles D. Pusey, C A Bowman, Andrew J. Rees, C M Lockwood	1986	165
19	Severe intestinal involvement in Wegener's granulomatosis. Gut ·Simon Haworth, Charles D. Pusey	1984	69
20	Gastrointestinal manifestations of systematic vasculitis QJM ·M. Camilleri, Charles D. Pusey, V. S. Chadwick, Andrew J. Rees	1983	3

About Charles D. Pusey

Charles D. Pusey is a scholar working on Nephrology, Immunology and Allergy, Genetics, Rheumatology and Pulmonary and Respiratory Medicine, having authored 323 papers that have together received 18.4k indexed citations. Recurring topics across this work include Vasculitis and related conditions (162 papers), Renal Diseases and Glomerulopathies (95 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (68 papers), Cell Adhesion Molecules Research (52 papers), Sarcoidosis and Beryllium Toxicity Research (31 papers), Urticaria and Related Conditions (26 papers), Otitis Media and Relapsing Polychondritis (26 papers) and Systemic Lupus Erythematosus Research (23 papers). The work is most often cited by research in Nephrology (5.7k citations), Genetics (4.1k citations), Pulmonary and Respiratory Medicine (10.9k citations), Rheumatology (4.7k citations) and Immunology and Allergy (1.7k citations). Charles D. Pusey has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include David Jayne, Jeremy Levy, Alan D. Salama, Andrew J. Rees, Stephen P. McAdoo, H. Terence Cook, Keith B. Elkon, John Lanham, Graham R.V. Hughes and C M Lockwood. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology, Nephrology Dialysis Transplantation, Lara D. Veeken and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact